Page 1 of Clinical Trials for Drug Aliskiren 300 mg, 105 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension
Last Updated: April 19, 2012
Condition(s): Hypertension
2
Completed
Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension
Last Updated: June 2, 2011
Condition(s): Hypertension
3
Completed
A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients
Last Updated: November 7, 2011
Condition(s): Hypertension
4
Completed
Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
Last Updated: July 15, 2008
Condition(s): Essential Hypertension
5
Completed
Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome
Last Updated: September 22, 2011
Condition(s): High Blood Pressure; Metabolic Syndrome; Insulin Resistance; Endothelial Dysfunction
6
Completed
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
Last Updated: April 7, 2011
Condition(s): Hypertension
7
Completed
Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension
Last Updated: May 4, 2011
Condition(s): Hypertension
8
Completed
Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
Last Updated: April 15, 2011
Condition(s): Post Acute Coronary Syndrome; Myocardial Ischemia
9
Terminated
Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema
Last Updated: February 2, 2012
Condition(s): Diabetic Macular Edema
10
Completed
Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
Last Updated: June 22, 2011
Condition(s): Hypertension
11
Completed
A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg
Last Updated: February 24, 2011
Condition(s): Hypertension
12
Completed
An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure
Last Updated: March 8, 2011
Condition(s): Hypertension
13
Recruiting
Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria
Last Updated: December 23, 2009
Condition(s): Hypertension; Type 2 Diabetes
14
Completed
Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone
Last Updated: June 30, 2011
Condition(s): Hypertension
15
Completed
Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine
Last Updated: March 7, 2011
Condition(s): Essential Hypertension
16
Completed
Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
Last Updated: February 28, 2011
Condition(s): Hypertension
17
Completed
Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
Last Updated: November 28, 2007
Condition(s): Diabetes Type 2
18
Completed
Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise
Last Updated: June 2, 2011
Condition(s): Hypertension
19
Recruiting
Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension
Last Updated: January 27, 2012
Condition(s): Hypertension
20
Recruiting
To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
Last Updated: August 8, 2011
Condition(s): Patients With Non-diabetic Nephropathy

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Aliskiren+300+mg

Page 1 of Clinical Trials for Drug Aliskiren 300 mg, 105 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About